Literature DB >> 870177

The interaction between radiation and adriamycin damage in mammalian cells.

J A Belli, A J Piro.   

Abstract

Interaction between radiation and Adriamycin damage reduced the width of the shoulder of the X-ray survival curve. This effect was found to persist for at least 24 hr after Adriamycin treatment. Adriamycin did not affect radiation damage when cells were treated either before two-dose fractionation or with the drug present between X-ray exposures. Adriamycin is unique in that its major effect on radiation response is to reduce the survival curve shoulder without affecting two-dose recovery. It is suggested that Adriamycin and radiation produce independent classes of damage that are expressed mutually for killing, with regard to the registration of sublethal radiation damage, but that repair of the latter is unaffected by Adriamycin.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 870177

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  9 in total

Review 1.  [Radiobiological mechanisms for new strategies in radiochemotherapy].

Authors:  K R Trott
Journal:  Strahlenther Onkol       Date:  1998-08       Impact factor: 3.621

2.  Effectiveness of AMSA alone or in combination with radiation on murine fibrosarcoma pulmonary nodules.

Authors:  D J Grdina; S Jones; N Hunter
Journal:  Clin Exp Metastasis       Date:  1984 Jul-Sep       Impact factor: 5.150

3.  Survival of intestinal crypts after treatment by adriamycin alone or with radiation.

Authors:  J V Moore; D A Broadbent
Journal:  Br J Cancer       Date:  1980-11       Impact factor: 7.640

4.  Enhanced killing of mammalian cells by radiation combined with m-AMSA.

Authors:  P B Roberts; B C Millar
Journal:  Br J Cancer       Date:  1980-11       Impact factor: 7.640

5.  Response kinetics of host and experimental solid tumour after adriamycin.

Authors:  H A Hopkins; W B Looney; K Teja; A S Hobson; M S MacLeod
Journal:  Br J Cancer       Date:  1978-06       Impact factor: 7.640

6.  Enhancement of tumor radio-response by irinotecan in human lung tumor xenografts.

Authors:  K Tamura; M Takada; I Kawase; T Tada; S Kudoh; K Okishio; M Fukuoka; N Yamaoka; Y Fujiwara; M Yamakido
Journal:  Jpn J Cancer Res       Date:  1997-02

7.  A comparison of adriamycin and mAMSA in vitro: cell lethality and SCE studies.

Authors:  C West; I J Stratford; N Barrass; E Smith
Journal:  Br J Cancer       Date:  1981-12       Impact factor: 7.640

8.  Cytotoxicity of adriamycin to tumour cells in vivo and in vitro.

Authors:  W M Martin; N J McNally
Journal:  Br J Cancer       Date:  1980-12       Impact factor: 7.640

9.  Triggered radiosensitizer delivery using thermosensitive liposomes and hyperthermia improves efficacy of radiotherapy: An in vitro proof of concept study.

Authors:  Helena C Besse; Clemens Bos; Maurice M J M Zandvliet; Kim van der Wurff-Jacobs; Chrit T W Moonen; Roel Deckers
Journal:  PLoS One       Date:  2018-09-18       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.